​

BioAtla (BCAB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

BioAtla Revenue Highlights

00

BioAtla Revenue by Period

BioAtla Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$250.00K-41.72%
2020-12-31$429.00K-91.75%
2019-12-31$5.20M-51.07%
2018-12-31$10.63M-

BioAtla generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

BioAtla Revenue by Quarter

DateRevenueChange
2025-03-31-100.00%
2024-12-31--100.00%
2024-09-30$11.00M100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.71M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$250.00K66.67%
2021-09-30$150.00K-40.00%
2021-06-30$250.00K100.00%
2021-03-31-100.00%
2020-12-31--100.00%
2020-09-30$150.00K-21.05%
2020-06-30$190.00K113.48%
2020-03-31$89.00K-95.96%
2019-12-31$2.20M-

BioAtla generated - in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

BioAtla Revenue Breakdown

BioAtla Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 21
Service$300.00K

BioAtla's latest quarterly revenue breakdown by segment (product or service), as of Jun 21: Service (100.00%).

BioAtla Revenue Breakdown by Country

Quarterly Revenue by Country

CountryJun 21
Service$300.00K

BioAtla's latest quarterly revenue breakdown by geography, as of Jun 21: Service (100.00%).

BioAtla Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRSNMersana Therapeutics$40.50M$3.06M
FGENFibroGen$29.62M$1.35M
CELUCelularity$22.77M$18.13M
GBIOGeneration Bio$19.89M$765.00K
QTTBQ32 Bio$1.16M-
INMBINmune Bio$14.00K$50.00K
LTRNLantern Pharma--
BCABBioAtla--
NRXPNRx Pharmaceuticals--
SKYESkye Bioscience--

BCAB Revenue FAQ

What is BioAtla’s yearly revenue?

BioAtla's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. BCAB's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is BioAtla’s quarterly revenue?

BioAtla's quarterly revenue for Q1 2025 was $0, a 100.00% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $0, a -100.00% decrease from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). BCAB's quarterly revenue for Q3 2024 was $11M, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is BioAtla’s revenue growth rate?

BioAtla's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.